Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Gelsomino F, Tiseo M, Barbieri F, Riccardi F, Cavanna L, Frassoldati A, Delmonte A, Longo L, Dazzi C, Cinieri S, Colantonio I, Sperandi F, Lamberti G, Brocchi S, Tofani L, Boni L, Ardizzoni A.
Gelsomino F, et al.
Br J Cancer. 2021 Jul;125(2):306. doi: 10.1038/s41416-021-01439-1.
Br J Cancer. 2021.
PMID: 34012035
Free PMC article.
No abstract available.